Boston Scientific Corp (NYSE: BSX) kicked off on Tuesday, at the price of On Tuesday, down -1.84% from the previous trading day, before settling in for the closing price of $106.79. Over the past 52 weeks, BSX has traded in a range of $71.88-$108.94.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -17.84%. While this was happening, its average annual earnings per share was recorded 18.85%. With a float of $1.47 billion, this company’s outstanding shares have now reached $1.48 billion.
Considering the fact that the conglomerate employs 53000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 68.27%, operating margin of 17.02%, and the pretax margin is 16.22%.
Boston Scientific Corp (BSX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Boston Scientific Corp is 0.58%, while institutional ownership is 92.51%. The most recent insider transaction that took place on Aug 01 ’25, was worth 5,231,670. In this transaction EVP & Group Pres, Cardiology of this company sold 50,000 shares at a rate of $104.63, taking the stock ownership to the 178,342 shares. Before that another transaction happened on Aug 01 ’25, when Company’s EVP& Grp Pres, MedSurg & APAC sold 17,313 for $104.63, making the entire transaction worth $1,811,520. This insider now owns 23,600 shares in total.
Boston Scientific Corp (BSX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 18.85% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.27% during the next five years compared to -17.84% drop over the previous five years of trading.
Boston Scientific Corp (NYSE: BSX) Trading Performance Indicators
Take a look at Boston Scientific Corp’s (BSX) current performance indicators. Last quarter, stock had a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.40. Likewise, its price to free cash flow for the trailing twelve months is 44.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.68, a number that is poised to hit 0.72 in the next quarter and is forecasted to reach 3.40 in one year’s time.
Technical Analysis of Boston Scientific Corp (BSX)
Compared to the last year’s volume of 7.67 million, its volume of 5.94 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 37.37%.
During the past 100 days, Boston Scientific Corp’s (BSX) raw stochastic average was set at 82.10%, which indicates a significant increase from 38.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.08 in the past 14 days, which was lower than the 2.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $103.76, while its 200-day Moving Average is $98.12.
